Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

NBIXNBIX
Showing 8 of 14 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in NEUROCRINE BIOSCIENCES INC

WELLINGTON MANAGEMENT GROUP LLP holds 1.4M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $183.1M as of 2026-Q1. The position was decreased (-20.4% shares). NBIX represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$183.1M

Current Shares

1.4M

Total Value Change

+$59.2M

Total Shares Change

+490,046

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.4M
-20.4%
$183.1M0.0%$131.14
0
2025-Q4
Decreased
1.7M
-3.7%
$247.4M0.0%$140.95
0
2025-Q3
Decreased
1.8M
-10.7%
$254.3M0.0%$140.27
0
2025-Q2
Decreased
2M
-3.3%
$255M0.0%$125.42
0
2025-Q1
Increased
2.1M
+44.0%
$232M0.0%$113.16
41
2024-Q4
Increased
1.5M
+102.9%
$198.9M0.0%$137.06
49
2024-Q3
Decreased
718,226
-20.1%
$82.8M0.0%$115.06
0
2024-Q2
Decreased
899,493
-10.4%
$123.8M0.0%$137.67
0

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used